Funding Announcement

Results of the 2024 Research Training Awards Competition

CCS’s research strategy centers people at its core and aims to deliver results that will significantly improve the outlook for people affected by cancer in Canada. By making a significant investment in the recruitment and training of cancer research trainees CCS hopes to strengthen the future of the cancer research ecosystem in Canada. 

CCS and its partners launched the 2024 Research Training Awards in December 2023. This award is intended to support growth and innovation in the next generation of diverse cancer researchers across Canada at the Master’s, Doctoral and Postdoctoral levels. It will support individuals in conducting cancer related research while fostering long term connections with Canada’s cancer research ecosystem through a combination of exposures to other disciplines, knowledge translation, engagement, and mentorship opportunities.

To address structural and systemic barriers to inclusion, and increase diverse representation in our cancer research ecosystem, we supported and encouraged Black and Indigenous trainees to apply at the PhD, and postdoctoral level. Black and Indigenous students only were invited to apply for the 2024 Master’s competition.   

We are pleased to announce the results of the 2024 Research Training Awards:

RTA 24 results announcement banner

In partnership with

Expert review process for the Research Training Awards

133 full applications were received and underwent review by 5 expert panels comprised of national scientific experts, as well as patient/survivor/caregiver reviewers with lived experience. 32 have been approved for funding – corresponding to a 24% success rate. These awards, with support from generous funding partners, total more than $4.7M in funding over the full term of these awards.  

To address structural and systemic barriers to inclusion, and increase diverse representation in our cancer research ecosystem, only Black and Indigenous students were invited to apply. 

5 full applications were received and underwent review by an expert panel comprised of national scientific experts, as well as patient/survivor/caregiver reviewers with lived experience. 

4 have been approved for funding – corresponding to an 80% success rate. These awards, with support from generous funding partners, total more than $163k in funding over the full term of these awards.  

76 full applications were received, and underwent review by 3 expert panels (Biomedical, Clinical, Social and Cultural, Environmental & Population Health) comprised of national scientific experts, as well as patient/survivor/caregiver reviewers with lived experience. 

15 have been approved for funding – corresponding to a 20% success rate. These awards, with support from generous funding partners, total more than $2.1 million in funding over the full term of these awards. 

52 full applications were received, and underwent review by 3 expert panels (Biomedical, Clinical, Social and Cultural, Environmental & Population Health) comprised of national scientific experts, as well as patient/survivor/caregiver reviewers with lived experience. 

13 have been approved for funding – corresponding to a 25% success rate. These awards, with support from generous funding partners, total more than $2.4 million in funding over the full term of these awards.  

RTA 24 results by goal

Investment by goal

RTA 24 results by goal
RTA 24 results by research focus graph

Investment by research area

RTA 24 results by research focus graph
Investment by cancer site

Investment by cancer site

Investment by cancer site
Results by province of trainee’s institution

Results by province of trainee’s institution

Results by province of trainee’s institution
Results by gender identity

Results by gender identity

Results by gender identity